(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 2.13% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 3.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12%.
Elevance Health's revenue in 2026 is $201,113,000,000.On average, 23 Wall Street analysts forecast ELV's revenue for 2026 to be $43,676,173,790,260, with the lowest ELV revenue forecast at $41,822,375,099,340, and the highest ELV revenue forecast at $46,126,579,897,970. On average, 22 Wall Street analysts forecast ELV's revenue for 2027 to be $44,710,640,303,560, with the lowest ELV revenue forecast at $41,894,592,572,910, and the highest ELV revenue forecast at $47,767,846,684,690.
In 2028, ELV is forecast to generate $46,615,186,408,340 in revenue, with the lowest revenue forecast at $43,155,470,624,970 and the highest revenue forecast at $50,104,830,153,730.